Form 4: Amgen VP Matthew C. Busch Reports Changes in Beneficial Ownership
SEC Form 4
Matthew C. Busch, VP of Finance & CAO at Amgen, filed a Form 4 disclosing changes in beneficial ownership of Amgen stock due to the disposition of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On March 18, 2024, Matthew C. Busch, VP of Finance & CAO at Amgen Inc., reported a transaction involving Amgen's common stock.
- The transaction involved the disposition of 146 shares at a price of $268.87 per share.
- This disposition was related to the satisfaction of tax obligations associated with the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Busch directly owns 4,670 shares of Amgen common stock, which includes various RSUs vesting at different dates in the future.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine sale of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/18/2024 | Date of transaction and filing of Form 4. |
| 05/05/2024 | 64 RSUs will vest. |
| 04/30/2024 | 41 RSUs will vest. |
| 11/05/2024 | 494 RSUs will vest. |
| 04/30/2025 | 43 RSUs will vest. |
| 11/05/2025 | 509 RSUs will vest. |
| 05/02/2024 | 70 RSUs will vest. |
| 05/02/2025 | 71 RSUs will vest. |
| 05/02/2026 | 73 RSUs will vest. |
| 05/02/2025 | 97 RSUs will vest. |
| 05/02/2026 | 98 RSUs will vest. |
| 05/02/2027 | 101 RSUs will vest. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.